BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/24/2026 9:14:05 AM | Browse: 0 | Download: 0
 |
Received |
|
2026-01-06 09:28 |
|
Peer-Review Started |
|
2026-01-06 09:29 |
|
First Decision by Editorial Office Director |
|
2026-01-16 03:05 |
|
Return for Revision |
|
2026-01-16 03:05 |
|
Revised |
|
2026-02-07 12:01 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-04-01 02:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-04-01 08:27 |
|
Articles in Press |
|
2026-04-01 08:27 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-06-08 15:46 |
|
Publish the Manuscript Online |
|
2026-06-24 09:14 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Expression of LHFPL2 in hepatocellular carcinoma and its association with prognosis after transarterial chemoembolization
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lei Sun, Kang Chen and Xiao-Li Zhu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xiao-Li Zhu, Chief Physician, MD, Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, No. 188 Shizi Road, Suzhou 215031, Jiangsu Province, China. zhuxiaoli90@163.com |
| Key Words |
Hepatocellular carcinoma; Lipoma HMGIC fusion partner-like 2; Transarterial chemoembolization; Transarterial chemoembolization resistance; Prognosis; Alpha-fetoprotein |
| Core Tip |
Lipoma HMGIC fusion partner-like 2 overexpression contributes to transarterial chemoembolization resistance in hepatocellular carcinoma patients and predicts unfavorable outcomes. The combination of lipoma HMGIC fusion partner-like and alpha-fetoprotein levels allows for improved prognostic assessment, offering a potential molecular marker for individualized treatment planning and early identification of transarterial chemoembolization non-responders (No. AF-SW-07-02.1). |
| Publish Date |
2026-06-24 09:14 |
| Citation |
Sun L, Chen K, Zhu XL. Expression of LHFPL2 in hepatocellular carcinoma and its association with prognosis after transarterial chemoembolization. World J Gastrointest Surg 2026; 18(6): 116682
|
| URL |
https://www.wjgnet.com/1948-9366/full/v18/i6/116682.htm |
| DOI |
https://doi.org/10.4240/wjgs.116682 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
